The syntheses of 1-and 7-hydroxypyrrolizidin-3-ones are described via asymmetric catalytic hydrogenation or diastereoselective reduction of ketones as key steps. 2,7-Disubstituted pyrrolizidin-3-ones are also prepared. The second chiral center is created using stereoselective electrophilic amination or hydroxylation reactions.
Introduction
Functionalized bicyclic lactams with the nitrogen atom at the bridgehead position are interesting structures well studied in the literature. One commonly encountered function of this skeleton is in the formation of rigid dipeptide mimics. 1 Moreover, these bicyclic systems are known to be effective intermediates in the preparation of alkaloids such as the polyhydroxylated pyrrolizidines or indolizidines, [2] [3] [4] and of more complex structures like lepadiformine 5 or furopyrrolizidinone. 6 The synthesis of pyrrolizidin-3-ones mono-or disubstituted at positions 1 or 7 was reviewed in 2000. 7 We have been interested in the preparation of such systems, in particular the (1R,7aS)-and (1S,7aS)-1-hydroxypyrrolizidin-3-ones (1 and 2) on one hand, and in a second line of study the O-protected (7S,7aS)-and (7R,7aS)-7-hydroxypyrrolizidin-3-ones (3 and 4) ( Figure 1 ). After treatment of 8 with TFA, the intermediate pyrrolidine was treated with potassium carbonate to give the expected (1S)-hydroxypyrrolizidin-3-one 2 (94% for the 2 steps) (Scheme 2).
We reported few years ago the catalytic hydrogenation of -ketoesters bearing a -lactam moiety. 21 The full syntheses of 3 and 4 from commercial pyroglutamic acid 10 are detailed next.
They began with the formation of the N-Boc protected 11 in three steps as described in the literature 22 (Scheme 3). The homologation using Masamune′s method led to the expectedketoester 12 in 67% yield after 4 days of reaction. In the earlier communication we reported the catalytic hydrogenation of 12 and showed that the best conditions for obtaining thehydroxyester 13 or its diastereoisomer 14 selectively was to use the catalyst under atmospheric pressure at 55 °C for 40 hours. We observed the removal of the tert-butoxycarbamate protecting group concomitantly with the hydrogenation reaction under these conditions. The -hydroxyester with the 3S configuration (13) can be obtained in 94% diastereomeric excess and in nearly quantitative yield by using the [(R)-BinapRu]Br 2 complex. The use of the (S)-catalyst led to the epimer 3R 14 as the sole isomer, also in good yield (89%).
Scheme 3.
Formation of the -hydroxyesters 13 and 14.
The transformation of 13 and 14, respectively, into the epimeric pyrrolizidinones 3 and 4 was effected through the sequences described below (Scheme 4). After protection of the hydroxy functions as tert-butyldimethylsilyl ethers (15: 75%, 17: 88%), a first assay of the selective reduction of the methyl ester group with calcium borohydride formed in situ led to 16 and 18 in yields of 81 and 69% respectively. The yields were improved by reaction of 15 and 17 with a large excess of sodium borohydride (15 equiv.) in methanol, giving the same products 16 or 18 in yields of 94 and 77%. Their cyclisation was previously performed in a short sequence: mesylation of the primary alcohol function, and cyclisation in the presence of potassium carbonate, leading to the pyrrolizidinones 3 and 4 in yields of around 60%. 21 The yields have now been increased by the use of sodium hydride in tetrahydrofuran, becoming 84 and 85% respectively for the two-step sequence.
Scheme 4.
Formation of the protected 7-hydroxypyrrolizidin-3-ones 3 and 4.
We have shown access to the monohydroxylated pyrrolizidin-3-ones 1-4 in d.e. of up to 99%. For the two pyrrolizidinones 1 and 2 prepared in three and four steps respectively from 5, the diastereoselectivity is analogous to previously reported values, and is particularly remarkable for 2 (d.e. 96%, overall yield 80%) via a catalytic hydrogenation. Nevertheless, the very short synthesis described for compound 1 (d.e. 70%) via low temperature reduction made this a particularly interesting and inexpensive scheme despite the moderate overall yield (50%). Finally, the (7S,7aS)-7-(tert-butyldimethylsilyloxy)pyrrolizidin-3-one (3) and its epimer (7R,7aS)-4 were reached in nine steps from PGA (10) in overall yields of 30% and 27% respectively and excellent diastereoselectivities.
In a second project our aims were the 2,7-disubstituted derivatives 2,7-dihydroxypyrrolizidin-3-one and 2-amino-7-hydroxypyrrolizidin-3-one. The new functionality at position 2 was introduced at the beginning of the synthesis. We tested firstly the amination and hydroxylation reactions of PGA (10) .
Beside the preparations of 3-amino -lactam described in the literature, [23] [24] [25] there are very few instances of the direct amination to the carbonyl of PGA. These last syntheses were based mainly on the reaction of the corresponding enolate with diphenylphosphoryl azide, 24 or the hydrogenation of the oxime formed by the action of Bredereck′s reagent followed by nitrous acid treatment. 25 In these two cases the relative configuration of the amino-PGA in the major product was always cis. We have developed a way of direct amination of protected PGA leading to the trans configuration in the product. The Boc-protected methyl pyroglutamate 19 26 was treated with 1.1 equivalents of LiHMDS at -78 °C for 1 hour, followed by addition of 2.0 equivalents of dibenzyl azodiformate (DBAD) in tetrahydrofuran at -60 °C (scheme 5). After purification, the expected hydrazino derivative 20 was obtained in 66% yield, as only one diastereomer (d.e.>95%, measured by NMR). The stereochemistry of the newly formed center of 20 was elucidated by conversion into the corresponding amine by a three-step sequence, namely, classical hydrogenation using Pd/C followed by the addition of Raney nickel in the reaction mixture, then by cleavage of the tert-butoxycarbonyl protecting group with TFA, leading to 21. The NMR spectral data of the product were in concordance with the structure of 21, and the trans configuration was proved by NOESY correlation studies. In particular, we found a strong effect between the protons H-4 and H-3b, and also between H-2, H-3a and NH 2 . There is clearly no effect between H-2 and H-4. All these results are in agreement with the (R) configuration of the newly formed aminated stereocenter, showing that the enolate was attacked by the azodicarboxylate at its less hindered side only, leading to the one diastereoisomer. This result was particularly interesting in being the first example of direct amination of a protected PGA leading to the corresponding derivative with the trans configuration.
Scheme 5. Electrophilic amination and hydroxylation of protected PGA.
The electrophilic hydroxylation of the enolate of 22 22 by 3-phenyl-N-p-toluenesulfonyloxaziridine (TPO) has been first described by Nozoe 27 and completed by Young 28 . The reaction led to the hydroxylated 23 with a d.e. >99% but in low yield (30%). We increased this yield to 55% by the action of TPO at -78 °C over 45 minutes followed by hydrolysis in the presence of camphorsulfonic acid (CSA) (Scheme 5). The d.e. was as good as those of the earlier authors, as only the trans isomer was obtained (d.e. >95%, measured by NMR studies). The newly-formed hydroxyl function was protected as a tert-butyldimethylsilyl ether under classical conditions to give 24 (92%). Thus, the 3-amino-and 3-hydroxy-APG have been prepared with excellent d.e. and in short preparative sequences. The fully-protected hydroxy compound 24 was used in the synthesis of 2,7-dihydroxypyrrolizidin-3-ones (Scheme 6).
To perform the synthesis of 2,7-dihydroxypyrrolizidin-3-ones, the carboxylic acid was first restored by hydrogenolysis of the benzyl ester of 24 and the subsequent homologation led to the The diol 28 was transformed into the corresponding bicyclic system 31 in four steps (Scheme 7). Regioselective silylation of 28 using triisopropylsilyl chloride in a mixture DMF/imidazole led to the intermediate 3′-triisopropylsilyloxy compound. The methyl ester was then reduced by the action of an excess of NaBH 4 , leading to 30. The primary alcohol was selectively tosylated and a cyclisation under basic conditions gave the pyrrolizidinone 31 with a yield of 43% for the 2 steps. The same sequence applied to 29 led to the compound 33 with a yield of 18% for the 4 steps.
A similar synthetic way is actually under progress for the obtaining of 2-amino-7-hydroxypyrrolizidin-3-one.
Finally, we tested the functionalization in of the carbonyl of the pyrrolizidinones 1, 2, 3 and 4 in the way to increase our pool of disubstituted pyrrolizidin-3-ones. The functionalization of the derivatives 1, 2 and 3 by electrophilic amination or hydroxylation failed. Only 4 led to the hydrazine 34 (Scheme 8) with the yield of 63% using strong conditions: 5.0 equivalents of LDA, then the addition of a solution containing 4.0 equivalents of DTBAD at -60 °C. In term of diastereoselectivity for 34, NOESY correlation studies showed that the irradiation of the proton H-2 induced an effect at the proton H-7a, which is in favour of a cis relation. When the proton H-7 was irradiated, no effect with the H-2 was observed that confirmed a 2S absolute configuration of the new asymmetric aminated center. 
Conclusions
In conclusion, we report the synthesis of seven mono-and di-substituted pyrrolizidin-3-ones from L-proline or L-pyroglutamic acid. Starting from L-proline, a very short synthetic sequence was developed to reach 1. Treatment of the -ketoester derived from L-proline with sodium borohydride resulted in a one pot reduction/cyclisation. The hydroxypyrrolizidin-3-ones 2, 3 and 4 were obtained using asymmetric catalytic hydrogenation as the key step. 2,7-Disubstituted pyrrolizidin-3-ones were synthesized from L-pyroglutamic acid. The chiral centers were created at C-2 by electrophilic amination or hydroxylation and at C-7 by catalytic hydrogenation as before. The two stereomeric 2,7-dihydroxypyrrolizidin-3-ones 31 and 33 were prepared by this way. The N,O-diprotected 2-hydrazino-7-hydroxypyrrolizidin-3-one 34 was obtained by direct electrophilic amination of the corresponding 7-hydroxypyrrolizidin-3-one 4. 
Methyl (2′S)-3-(N-tert-butoxycarbonyl-2′-pyrrolidinyl)-3-oxopropanoate (6)
.
Methyl (2′S)-3-(2′-pyrrolidinyl)-3-oxopropanoate, trifluoroacetate salt (7)
. TFA (1.5 mL) was added to 6 (200 mg) and the overall was stirred during 15 min. Concentration in vacuo led to the crude 7 (99%), which was too unstable for analysis and was directly introduced in the next reaction; 1 The impure salt was retaken in water (1.5 mL) and K 2 CO 3 (287 mg) was added. After stirring 3 h at 90 °C, the reaction mixture was concentrated and the crude was purified by silica gel chromatography (EtOAc/ MeOH: 85/15) to give 2 (161 mg, 94% from 8). NMR spectral data are in accordance with those in the literature 12b .
Methyl (2′S)-3-oxo-(N-tert-butoxycarbonyl-5′-oxopyrrolidin-2′-yl)propanoate (12).
Magnesium chloride (920 mg, 9.8 mmol, 1.6 equiv.) was added to a solution of potassium monomethyl malonate (2.60 g, 16.5 mmol, 2.7 equiv.) in dry THF (38 mL). The reaction mixture was cooled at 0 °C, then triethylamine (2.6 mL, 18.3 mmol, 3.0 equiv.) was added and the whole was stirred at this temperature for 80 min. In another flask, a solution of 11 22 (1.40 g, 6.1 mmol)
in dry THF (8.4 mL) was added to carbonyldiimidazole (1.09 g, 6.7 mmol, 1.1 equiv.) in DMF (6.7 mL) and stirred for 40 minutes at room temperature. The second solution was then added to the salt at 0 °C, and the reaction mixture was warmed to room temperature then stirred for four days. After filtration, the filtrate was diluted with water (50 mL) and extracted with EtOAc (7 × 30 mL). The organic layers were washed with brine (50 mL), dried, then concentrated in vacuo to give a yellow oil. Purification by silica gel chromatography (EtOAc) gave 12 ( 
Methyl (2′S,3S)-3-(tert-butyldimethylsilyloxy)-3-(5′-oxopyrrolidin-2′-yl)propanoate (15).
Under argon, a solution of imidazole (771 mg, 11.3 mmol, 2.6 eq.) in dry DMF (9.7 mL) was cannulated to a flask containing 13 (816 mg, 4.4 mmol). tert-butyldimethylsilyl chloride (1.18 g, 7.8 mmol, 1.8 eq.) was added and the reaction mixture was stirred at room temperature during 24 h. Water was then added (10 mL), and the compound was extracted with Et 2 O (4 × 10 mL). The organic layers were dried and concentrated under vacuum to give a crude product which after purification by silica gel chromatography (EtOAc) gave 15 ( 
2′S,3S)-3-(tert-Butyldimethylsilyloxy)-3-(5′-oxopyrrolidin-2′-yl)propanol (16).
Sodium borohydride (1.83 g, 48.2 mmol, 15.0 eq.) was added slowly to a solution of 15 (967 mg, 3.2 mmol) in dry MeOH (10 mL) at 0 °C under argon. After 2h 30m of stirring at room temperature, brine (2 mL) then an aqueous solution of HCl 1N was added until neutral pH. The aqueous layer was extracted with DCM (5 × 10 mL), and the organic layers were dried and concentrated in vacuo. 
(7S,7aS)-7-(tert-Butyldimethylsilyloxy)pyrrolizidin-3-one (3).
To a solution of 16 (135 mg, 0.5 mmol) in dry DCM (3 mL) under argon was added methanesulfonyl chloride (132 L, 1.7 mmol, 3.5 equiv.) then freshly distilled triethylamine (180 L, 1.3 mmol, 2.6 equiv.). After stirring 12 hours, EtOAc (10 mL) was added and the organic layer was washed successively with distilled water (5 mL), a saturated aqueous solution of NaHCO 3 (5 mL), then brine (5 mL). After drying, filtration and concentration under vacuo, the orange oil was retaken into anhydrous THF (9 mL) under argon and cooled at 0 °C. Sodium hydride (suspension in oil 60%, 40 mg, 1.0 mmol, 2.0 equiv.) was added to the reaction mixture and the overall was stirred at room temperature during 24 h. After hydrolysis with aqueous saturated NH 4 Cl until neutral pH, the aqueous layer was extracted with EtOAc (3 × 5 mL). The organic layers were dried, concentrated for give a crude which was purified by silica gel chromatography (EtOAc) to led to 3 (84 % (7R,7aS)-7-(tert-Butyldimethylsilyloxy)pyrrolizidin-3-one (4) 0 mmol, 1.5 equiv.) in anhydrous THF (87 mL) was added. After an additionnal 45 min, the reaction mixture was quenched with a solution of CSA (0.5M in THF, 5.0 equiv.) and let warm to room temperature. Then water (500 mL) was added, and the crude was extracted with DCM (5 × 250 mL). The organic layers were successively washed with a solution of saturated sodium thiosulfate (500 mL), then brine (500 mL), and then dried and concentrated togive a crude material which was purified by silica gel chromatography ( Under argon, carbonyldiimidazole (1.5 g, 9.3 mmol, 1.2 equiv.) was added to a solution of the acid (2.8 mg, 7.8 mmol) in dry THF (64 mL) and the mixture was stirred 16 h at room temperature. In another flask, to a solution of potassium monomethyl malonate (4.3 g, 27.3 mmol, 3.5 equiv.) in dry THF (33 mL) at 5 °C was added triethylamine (5.0 mL, 35.9 mmol, 4.6 equiv.) and magnesium chloride (3.1 g, 33.5 mmol, 4.3 equiv.). The overall was stirred at room temperature during 3 h then cooled again at 0 °C before the addition of the acylimidazolide previously prepared. The reaction mixture was let warmed to room temperature then stirred during 4 days. THF was evaporated and the residue was dissolved in aqueous 1M HCl until pH 5-6. After extraction with DCM (5 × 300 mL), the organic layers were dried and concentrated. A purification by silica gel chromatography (Et 2 
Methyl (2′S,3R)-3-(tert-Butyldimethylsilyloxy)-3-(5′-oxopyrrolidin-2′-yl)propanoate (17

Methyl (2S,4R)-1-tert-butoxycarbonyl-4-[N,N′-di(benzyloxycarbonyl)hydrazino]-5-oxopyrrolidine-2-carboxylate (20)
Methyl (2′R,4′S)-3-(N-tert-butoxycarbonyl-4′-hydroxy-5′-oxopyrrolidin-2′-yl)-3-oxopropanoate (26).
Under argon, TBAF (1M in THF, 0.9 mL, 0.9 mmol, 1.5 equiv.) was added to a solution of 25 (263 mg, 0.6 mmol) in dry THF (22.5 mL). After stirring 2.5 h, brine (22 mL) was added and the aqueous layer was extracted with EtOAc (5 × 45 mL). The organic layers were dried, concentrated and purified by silica gel chromatography (EtOAc) 508.2810.
